Adherence to treatment guidelines in clinical practice: Study of antipsychotic treatment prior to clozapine initiation

British Journal of Psychiatry

Volumn 201, Issue 6, 2012, Pages 481-485

  Howes, Oliver D ^a,b   Vergunst, Francis ^a   Gee, Siobhan ^b   McGuire, Philip ^a,b   Kapur, Shitij ^a,b   Taylor, David ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; REMOXIPRIDE; RISPERIDONE; SERTINDOLE; ZIPRASIDONE; ZOTEPINE;

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL PRACTICE; DEMOGRAPHY; DEPRESSIVE PSYCHOSIS; DISEASE DURATION; DRUG MEGADOSE; ETHNIC DIFFERENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; POLYPHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEX DIFFERENCE; THERAPY DELAY;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DRUG RESISTANCE; DRUG SUBSTITUTION; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; POLYPHARMACY; PRACTICE GUIDELINES AS TOPIC; SCHIZOPHRENIA; TIME-TO-TREATMENT;

EID: 84870327506     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.111.105833     Document Type: Article

References (27)

1. Mortimer AM, Singh P, Shepherd CJ, Puthiryackal J. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world. Clin Schizophr Relat Psychoses 2010; 4: 49-55.
2. Lieberman JA, Kane JM, Johns CA. Clozapine: guidelines for clinical management. J Clin Psychiatry 1989; 50: 329-38. (Pubitemid 19239055)
3. National Collaborating Centre for Mental Health. Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Adults in Primary and Secondary Care (Updated edn). National Clinical Guideline 82. British Psychological Society and the Royal College of Psychiatrists, 2010.
4. Taylor D, Paton C, Kapur S. The Maudsley Prescribing Guidelines (10th edn). Informa Healthcare, 2010.
5. Tiihonen J, Haukka J, Taylor M, Haddad PM, Patel MX, Korhonen P. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. Am J Psychiatry 2011; 168: 603-9.
6. Harrison J, Janlov M, Wheeler AJ. Patterns of clozapine prescribing in a mental health service in New Zealand. Pharm World Sci 2010; 32: 503-11.
7. Kelly DL, Kreyenbuhl J, Dixon L, Love RC, Medoff D, Conley RR. Clozapine underutilization and discontinuation in African Americans due to leucopenia. Schizophr Bull 2007; 33: 1221-4. (Pubitemid 47347911)
8. Taylor DM, Young C, Paton C. Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review. J Clin Psychiatry 2003; 64: 30-4. (Pubitemid 36182226)
9. Wheeler AJ. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand. Ann Pharmacother 2008; 42: 852-60. (Pubitemid 351778093)
10. Barnes TR. Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2011; 25: 567-620.
11. National Institute for Health and Clinical Excellence. Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (Clinical Guideline 1). London: NICE, 2002.
12. Agid O, Remington G, Kapur S, Arenovich T, Zipursky RB. Early use of clozapine for poorly responding first-episode psychosis. J Clin Psychopharmacol 2007; 27: 369-73. (Pubitemid 47075508)
13. Agid O, Arenovich T, Sajeev G, Zipursky RB, Kapur S, Foussias G, et al. An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis. J Clin Psychiatry 2011; 72: 1439-44.
14. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. WHO, 1992.
15. Joint Formulary Committee. British National Formulary (BNF59). BMJ Group and Pharmaceutical Press, 2010.
16. Barnes TR, Paton C. Antipsychotic polypharmacy in schizophrenia: benefits and risks. CNS Drugs 2011; 25: 383-99.
17. Howes OD, Egerton A, Allan V, McGuire P, Stokes P, Kapur S. Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging. Curr Pharm Des 2009; 15: 2550-9.
18. Howes OD, Bhatnagar A, Gaughran FP, Amiel SA, Murray RM, Pilowsky LS. A prospective study of impairment in glucose control caused by clozapine without changes in insulin resistance. Am J Psychiatry 2004; 161: 361-3. (Pubitemid 38419289)
19. Howes OD, Wheeler MJ, Meaney AM, O'Keane V, Fogelman I, Blake G, et al. Bone mineral density and its relationship to prolactin levels in patients taking antipsychotic treatment. J Clin Psychopharmacol 2005; 25: 259-61. (Pubitemid 40685791)
20. Howes OD, Wheeler MJ, Pilowsky LS, Landau S, Murray RM, Smith S. Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder. J Clin Psychiatry 2007; 68: 361-7. (Pubitemid 46506799)
21. Buchanan RW, Kreyenbuhl J, Kelly DL, Noel JM, Boggs DL, Fischer BA, et al. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull 2010; 36: 71-93.
22. Kelly DL, Dixon LB, Kreyenbuhl JA, Medoff D, Lehman AF, Love RC, et al. Clozapine utilization and outcomes by race in a public mental health system: 1994-2000. J Clin Psychiatry 2006; 67: 1404-11. (Pubitemid 44583388)
23. Taylor D, Shapland L, Laverick G, Bond J, Munro J. Clozapine: a survey of patient perceptions. Psychiatr Bull 2000; 24: 450-2.
24. Angermeyer MC, Loffler W, Muller P, Schulze B, Priebe S. Patients' and relatives' assessment of clozapine treatment. Psychol Med 2001; 31: 509-17. (Pubitemid 32294049)
25. Downs J, Zinkler M. Clozapine: national review of postcode prescribing. Psychiatr Bull 2007; 31: 384-7. (Pubitemid 47565022)
26. Tang YL, Mao PX, Jiang F, Chen Q, Wang CY, Cai ZJ, et al. Clozapine in China. Pharmacopsychiatry 2008; 41: 1-9. (Pubitemid 351195886)
27. Nielsen J, Dahm M, Lublin H, Taylor D. Psychiatrists' attitude towards and knowledge of clozapine treatment. J Psychopharmacol 2010; 24: 965-71.